If you're looking to dust off that original Xbox and play Halo 2 but wish you could hop on the servers like you did in the late 2000s, well, now you can, thanks to a group of devoted fans. Those fans ...

The Arknights: Endfield update 1.2 release is almost here. The new update, "At the Wake of Spring," includes a core chapter in the Wuling storyline, a new 6-star electric striker, a multi-character ...

Two arrests have been made after a possible gunshot was fired near the San Francisco home of OpenAI CEO Sam Altman early Sunday, just two days after a man allegedly threw a Molotov cocktail at his ...

Add Yahoo as a preferred source to see more of our stories on Google. “We had no idea what was going on at all,” Dearden tells ELLE. “Isa looked at me [one day] and said ‘Did you have a fitting?’ I ...

It’s July 20, 1969. Neil Armstrong and Buzz Aldrin are about to land on the moon. They will be the first humans to set foot ...

At a trendy venue near the San Francisco pier, Sam Altman’s verification project World celebrated its next evolution and rapid expansion of its ambitions. And it’s starting with Tinder. Tools for ...

World ID allows individuals to verify their ‘humanity’ through iris scanning via the company’s Orb device or simpler methods. In a world where it gets increasingly difficult to differentiate between ...

Retirement means more time to spend with your friends and family. While you haveplenty of freedom, it isn't always the financial kind. And that means you'reliving on a fixed income. Don't squander ...

Sam Roush is the latest Stanford tight end hoping to make his mark on the NFL. Roush was a third-round draft pick Friday in the NFL Draft by the Chicago Bears, No. 69 overall, after playing four ...

OpenAI CEO Sam Altman’s San Francisco home was allegedly targeted for the second time in two days – and cops have made two arrests. A Honda car had been near Altman’s $27 million Russian Hill mansion ...

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors ...